SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001341004-13-000921
Filing Date
2013-09-16
Accepted
2013-09-16 09:47:40
Documents
3

Document Format Files

Seq Description Document Type Size
1 OTSUKA HOLDINGS CO., LTD. TENDER OFFER scto_ta.htm SC TO-T/A 211194
2 LOGO 1 logo1.jpg GRAPHIC 11832
3 FOOTER LOGO footerlogo.jpg GRAPHIC 4262
  Complete submission text file 0001341004-13-000921.txt   235301
Mailing Address 4140 DUBLIN BLVD STE 200 DUBLIN CA 94568
Business Address 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100
Astex Pharmaceuticals, Inc (Subject) CIK: 0000919722 (see all company filings)

IRS No.: 911841574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-48769 | Film No.: 131097791
SIC: 2834 Pharmaceutical Preparations

Mailing Address SHINAGAWA GRAND CENTRAL TOWER 2-16-4 KONAN, MINATO-KU TOKYO M0 108-8242
Business Address SHINAGAWA GRAND CENTRAL TOWER 2-16-4 KONAN, MINATO-KU TOKYO M0 108-8242 011-81-3-6717-1400
Otsuka Holdings Co., Ltd. (Filed by) CIK: 0001586698 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0314
Type: SC TO-T/A